Latest Breaking News On - பயனர் வழிகாட்டி - Page 21 : vimarsana.com

United Therapeutics Announces Commercial Launch Of The Remunity® Pump For Remodulin® News provided by Share this article Share this article SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2021 /PRNewswire/  United Therapeutics Corporation (Nasdaq: UTHR) announced today that it has launched commercial sales of the innovative Remunity ® Pump for Remodulin ® for patients with pulmonary arterial hypertension (PAH). We are excited to bring to market the first subcutaneous pump designed specifically for PAH patients, said Beth Rhodes, Vice President, Global Supply Chain & Alliance Management at United Therapeutics. Remunity is a small, discreet pump that delivers Remodulin in prefilled cassettes that are delivered directly to patients, offering significant improvements over current subcutaneous pumps.

United statesDean kamenBeth rhodesDewey steadmanExchange commissionUnited therapeutics corporation nasdaqUnited therapeutics corporationUnited therapeutics corpDevelopment corporationCustomer serviceVice presidentGlobal supply chainAlliance managementUnited therapeuticsRemunity pumpSafety information